Register to chat with like-minded investors on our interactive forums.
| Share Name | Share Symbol | Market | Type |
|---|---|---|---|
| Acrivon Therapeutics Inc | NASDAQ:ACRV | NASDAQ | Common Stock |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 6.50 | 0 | 10:22:23 |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| 6.00 | 6.69 | ||||
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| Pharmaceutical Preparations | -60.39M | -1.9395 | -3.35 | 202.39M |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | 0 | 6.50 | USD |
| Date | Time | Source | Headline |
|---|---|---|---|
| 28/11/2023 | 13:58 | DJN | Acrivon Therapeutics Gets FDA's Breakthrough Designation for Cancer Assay |
Acrivon Therapeutics (ACRV) Share Charts1 Year Acrivon Therapeutics Chart |
|
1 Month Acrivon Therapeutics Chart |
Intraday Acrivon Therapeutics Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
